Table 1.
Patient Demographic and Baseline Variables
| Usual care (N=506) | Tool intervention (N=495) | |
|---|---|---|
| Age, mean (SD) | 69.0 (±10.0) | 68.9 (±10.5) |
| Sex, male, n (%) | 308 (60.%) | 294 (59.4) |
| Race and ethnicity, n (%) | ||
| Non‐Hispanic White | 356 (70.4) | 378 (76.4) |
| Hispanic or Latino | 33 (6.5) | 12 (2.4) |
| Asian | 14 (2.8) | 22 (4.4) |
| Black or African American | 92 (18.2) | 77 (15.6) |
| American Indian or Alaskan Native | 0 (0.0) | 1 (0.2) |
| Native Hawaiian or other Pacific Islander | 1 (0.2) | 2 (0.4) |
| Other or multiple | 10 (2.0) | 3 (0.6) |
| Highest level of education, n (%) | ||
| No college | 156 (30.8) | 172 (34.7) |
| College | 239 (47.2) | 222 (44.8) |
| Postgraduate | 95 (18.8) | 86 (17.4) |
| Decline to state | 16 (3.2) | 15 (3.0) |
| Anticoagulant use duration ≤6 months or never been on, n (%) | 244 (48.2) | 241 (48.7) |
| CHA2DS2VASc score, mean (SD) | 3.4 (±1.5) | 3.4 (±1.6) |
| Low AF stroke risk, n (%)* | 250 (49.4) | 248 (50.1) |
| Diabetes, n (%) | 125 (24.7) | 136 (27.5) |
| Hypertension, n (%) | 410 (81.0) | 397 (80.2) |
| Prior stroke/TIA, n (%) | 62 (12.3) | 64 (12.9) |
| Vascular disease, n (%) | 165 (32.6) | 160 (32.3) |
| Age, y, 65–74, n (%) | 237 (46.8) | 208 (42.0) |
| Age, y, >75, n (%) | 142 (28.1) | 150 (30.3) |
| Atrial Fibrillation Severity Scale total burden | ||
| n (%) | 496 (98) | 483 (98) |
| Median (min, max) | 14.0 (3.0, 30.0) | 13.0 (3.0, 30.0) |
| AF knowledge, median (min, max) | ||
| n (%) | 505 (>99) | 493 (>99) |
| Median (min, max) | 6.0 (0.0, 8.0) | 6.0 (0.0, 8.0) |
AF indicates atrial fibrillation; and TIA, transient ischemic attack.
*
Low risk: Male CHA2DS2‐VASc score <3 or female CHA2DS2‐VASc score <4.